n in trial
Selected Abstract
Moxifloxacin yields superior corneal penetration in trial
Topical agents Peak fluoroquinolone concentration achieved in epithelium reach 81.2 g/g, report shows Reviewed by Terry Kim, MD Chicago-After topical administration, moxifloxacin 0.5% (Vigamox, Alcon Laboratories) penetrates better into the cornea than gatifloxacin 0.3% (Zymar, Allergan) to achieve ... November 15, 2005; Ophthalmology Times
Read the full article with a free-trial membership at HighBeam Research
Related Articles No Results Found.
|
